pyridostigmine bromide has been researched along with Muscular Atrophy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blobner, M; Fink, H; Frick, CG; Helming, M; Martyn, JA | 1 |
Kurisaki, H; Ono, S | 1 |
Tallis, RC; Vellodi, C | 1 |
3 other study(ies) available for pyridostigmine bromide and Muscular Atrophy
Article | Year |
---|---|
Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness.
Topics: Animals; Atracurium; Cholinesterase Inhibitors; Disease Models, Animal; Hindlimb; Immobilization; Infusion Pumps; Infusions, Subcutaneous; Male; Muscle Contraction; Muscle Strength; Muscle Weakness; Muscular Atrophy; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic | 2010 |
[Spinal muscular atrophy with features of myasthenia gravis and Eaton-Lambert syndrome. A case report].
Topics: Electromyography; Humans; Male; Middle Aged; Muscular Atrophy; Myasthenia Gravis; Neuromuscular Diseases; Pyridostigmine Bromide; Synaptic Transmission; Syndrome | 1988 |
An unusual case of myasthenia gravis in an elderly patient with severe muscular atrophy.
Topics: Aged; Aged, 80 and over; Female; Humans; Muscular Atrophy; Myasthenia Gravis; Pyridostigmine Bromide | 1988 |